| Literature DB >> 25848616 |
Arvela R Heider1, Nancy A Maloney2, Nikhil Satchidanand3, Geoffrey M Allen3, Raymond Mueller2, Steven Gangloff3, Ranjit Singh3.
Abstract
BACKGROUND ANDEntities:
Keywords: Health Information Technology; Platforms; Quality Improvement
Year: 2014 PMID: 25848616 PMCID: PMC4371451 DOI: 10.13063/2327-9214.1089
Source DB: PubMed Journal: EGEMS (Wash DC) ISSN: 2327-9214
Figure 1.Strategy
Clinical Transformation Partners
| Catholic Medical Partners (CMP) | P2 Collaborative of Western New York | |
| Independent Practice Association | Informal Collection of Providers | |
| 65 | 33 | |
| 152 | 192 |
WNY Beacon Diabetes Registry Elements
|
Unique patient ID Age (yrs.) Gender (M/F) Race (text) Ethnicity (text) Language (text) Date of most recent visit Diabetes type (1 or 2) Comorbid conditions (Y/N for each of 9 conditions based on ICD-9 codes) Number of medications on active medication list Documentation of allergies (Yes or No) Most recent HbA1c value, with date Most recent LDL value, with date Most recent urine microalbumin/creatinine ratio result, with date Influenza vaccine status within past 12 months (Y/N), with date of most recent vaccination Pneumococcal vaccine status (Y/N), with date of most recent vaccination Most recent smoking status (text), with date of status Most recent blood pressure reading (systolic and diastolic), with date |
Figure 2.Percentage of Registry Data Deemed Invalid: Baseline (Q1 2012) to Endpoint (Q2 2013)
Notes: *Difference (baseline to endpoint) is significantly different at p<.001. Values represent the percentage of reported data that were deemed invalid (value or date not within an acceptable range). Acceptable ranges for laboratory values were: HbA1c 1 – 100%; LDL 1 – 300 mg/dL; Systolic BP 50–300 mmHg; Diastolic BP 35–200 mmHg; microalbumin/creatinine ratio 0–5000. Valid dates were within 12 months prior to the registry run date.
Figure 3.Example of Practice Benchmark Report
Notes: DM 1YR = type of Diabetes Mellitus (1 or 2) was specified; HbA1c 1YR = Hemoglobin A1c was recorded within the last year; HbA1c<9 = HbA1c result <9.0 within lastyear; LDLc 1YR = Low Density Lipoprotein (LDL) recorded in last year; LDLc<100 = LDL result <100mg/dLwithin last year; BP<140/90 = Most recent blood pressure systolic <140 and diastolic <90; ACR 1YR = microalbumin/creatinine ratio (ACR) recorded within lastyear; FLU 1YR = Influenza immunization recorded within lastyear; and PN 10YR = Pneumonia immunization recorded within last 10 years.
Findings
|
85 of 98 primary practices were able to produce a diabetes registry meeting community specifications. 65 of the 85 practices with registries were determined credible for benchmarking. Registry data quality (as measured by % of data deemed invalid) improved over time for 3 of 4 critical registry elements. Practices used the registries for population health management. Practices used both registries and benchmark reports to drive improvement. |
Lessons Learned
Establish clear technical specifications for the registry. Invest effort in data mapping. Anticipate the need for data normalization. Develop clear protocols to support practice staff. Understand that practices and vendors are both overwhelmed and don’t speak the same language. Anticipate that vendors have competing priorities. Learn how to work with vendors. |
Learn how to work with practices. Address data sharing concerns up front. Use peer groups to provide legitimacy. Leverage existing relationships to gain momentum. Gain buy-in by showing value to practices. |